Determination of residual organic solvents in a new cardioprotective compound by gas chromatography
- Authors: Kompantseva E.V1, Lutsenko D.N1, Larsky M.V1
-
Affiliations:
- Pyatigorsk Medical and Pharmaceutical Institute - branch of the Volgograd State Medical University of the Ministry of Health of Russia
- Issue: Vol 24, No 10 (2021)
- Pages: 52-58
- Section: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112892
- DOI: https://doi.org/10.29296/25877313-2021-10-07
- ID: 112892
Cite item
Abstract
Relevance. Gas chromatography - a method that allows you to quickly and accurately conduct a qualitative and quantitative analysis of the components of various mixtures, as well as divide them into their component parts - is widely used in various industries, including pharmaceutical. The purpose of this study was to develop and validate a method for determining residual organic solvents in the substance of the biologically active compound (BAS) N-[2-[4-oxo-3(4h)-quinazolinyl]propionyl]-guanidine (VMA-13-15) by gas chromatography. Material and methods. The objects of the study were laboratory samples of BAS VMA-13-15 (series 2017, 2018 and 2019), as well as CO methanol (GSO 8461-2003) and diethyl ether (OST-84-2006-88) qualifications of the he. Results. A method for the determination of residual organic solvents in the BAS substance N-[2-[4-oxo-3(4h)-quinazolinyl]propionyl]-guanidine by gas chromatography has been developed. The method was validated according to the following indicators: specificity, linearity, correctness and precision. Conclusions. The method for determining the residual organic solvents of N-[2-[4-oxo-3(4h)-quinazoline]propionyl]-guanidine can be recommended for inclusion in the draft regulatory documentation.
Keywords
Full Text
About the authors
E. V Kompantseva
Pyatigorsk Medical and Pharmaceutical Institute - branch of the Volgograd State Medical University of the Ministry of Health of RussiaDr.Sc. (Pharm.), Professor, Department of Pharmaceutical Chemistry Pyatigorsk, Russia
D. N Lutsenko
Pyatigorsk Medical and Pharmaceutical Institute - branch of the Volgograd State Medical University of the Ministry of Health of Russia
Email: lucenkodasha95@mail.ru
Post-graduate Student, Department of Pharmaceutical Chemistry Pyatigorsk, Russia
M. V Larsky
Pyatigorsk Medical and Pharmaceutical Institute - branch of the Volgograd State Medical University of the Ministry of Health of RussiaPh.D.(Pharm.), Head of the Department of Pharmaceutical Chemistry Pyatigorsk, Russia
References
- Патент № 2622638 (РФ). Производные хиназолин -4(3н)-она, обладающие ненро- н карднопротекторной активностью / В.И. Петров, И.Н. Тюренков, А А. Озеров, М.С. Новиков и др. 2016129010 заявл., 14.07.2016; опубл. 19.06.17. Бюл. № п.
- Глухова Е.Г. Синтез н фармакологические свойства новых карбонильных производных хнназолнн-4(ЗН)-она: Автореф. днсс.. канд. фарм. наук: 14.04.12. Волгоград: Волг. мед. университет. 2016; 120 с.
- Государственная фармакопея Российской Федерации. Изд. XIV. М.: М3 РФ, 2018. Т. 1. [Электронный ресурс].
- Луценко Д.Н., Компанцева Е.В. Изучение физико-химических свойств субстанции нового биологически активного соединения хнназолин-4(ЗН)-она. Разработка, исследование н маркетинг новой фармацевтической продукции. Сб. науч. трудов. 2018; 24-27.
- Общая фармакопейная статья 1.1.0012.15. Валидация аналитических методик. Государственная фармакопея Российской Федерации. Изд. ХШ. Т. I. М.; 2015. Avaitablefrom: http://femb.ru/fehn.
- Дерффель К. Статистика в аналитической химии. М.: Мир. 1994: 268 с.
- Daksh S., et al. Validation of analytical methods - Strategies &Singficance. Int. J. Res. Dev. Phann. L. Sci. April-May 2015; 4(3): 489-1497.